Completed NCT00378183
This study is completed. It focuses on schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries
Sponsor Janssen, LP
Condition Schizophrenia Completed NCT01143077
This study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries United States
Sponsor Sumitomo Pharma America, Inc.
Condition Schizophrenia Completed NCT02636842
This study is completed in the United States. It is testing aripiprazole Lauroxil for schizophrenia.
Multiple locations, including Cerritos Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Alkermes, Inc.
Condition Schizophrenia Completed NCT00297388
This study is completed. It is testing How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections for schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 70 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia Completed NCT00791622
This study is completed. It is testing QT and QTc Intervals for Schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 50 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia Completed NCT00791349
This study is completed. It is testing QT and QTc Intervals for Schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 50 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia Completed NCT01143090
This study is completed in the United States. It is testing subjects Switched to Lurasidone for schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries United States
Sponsor Sumitomo Pharma America, Inc.
Condition Schizophrenia Completed NCT00206102
This study is completed in the United States. It is testing cataractogenic Potential of Seroquel and Risperdal for schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor AstraZeneca
Condition Schizophrenia Completed NCT00649064
This study is completed in Taiwan. It is testing effects of Ziprasidone for schizophrenia.
Multiple locations, including Changhua Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries Taiwan
Sponsor Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition Schizophrenia Completed NCT00650429
This study is completed in Mexico. It is testing ziprasidone for schizophrenia.
Multiple locations, including Monterrey Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 70 Years
Countries Mexico
Sponsor Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition Schizophrenia Terminated NCT00645229
This study was terminated in Portugal. It is testing ziprasidone for schizophrenia.
In Lisbon Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 60 Years
Countries Portugal
Sponsor Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition Schizophrenia Completed NCT06003036
This summary needs review. Please check the official study record and contact the research team for details.
In Pittsburgh Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Device i A study involving a tool, app, wearable, test, or medical device. From 18 Years to 65 Years
Countries United States
Sponsor Deepak K. Sarpal, M.D.
Condition Schizophrenia